For the Future
New Biologics Business
New biotech business (cell therapy)
Hybrid Structure for Business Operations
Virtual business structure and Project management
Establishment of Cell Therapy Platform
IR Policy / Disclaimer
Major financial indicators over the past five years
(Scroll horizontally by tapping)
Note:The Company conducted a 2-for-1 stock split on October 1, 2016.
Above per share indicators have been calculated as if this stock split had taken place at the beginning of FY3/2015.